CClinicalTrials.gg
CompletedNCT03879304RVDuchenneUpdated May 13, 2024

Effectiveness of a Multimodal Physiotherapy Program With Virtual Reality Glasses in Duchenne and Becker.

An interventional study of multimodal physiotherapy program with RV and traditional physiotherapy program in Muscular Dystrophy, Duchenne and Becker Types, sponsored by University of Malaga. Completed at 1 site in Spain. Open to participants aged 4 Years to 15 Years. Per ClinicalTrials.gov, last updated 2024-05-13.

Sponsored by University of Malaga · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Randomized
Ages
4 Years to 15 Years
Sex
All
01

Study summary

Duchenne's Muscular Dystrophy and Becker Dystrophy, hereafter DMD and BMD, is a serious and progressive disease that affects 1 in 3,500-6,000 males born alive. Scale 6-minute walking test, is used for determine the inclusion of children with DMD in pharmacological studies. Furthemore, is used to verify a training effectiveness assessing muscular endurance and cardio-respiratory functions. This Research evaluates the feasibility and effectiveness of a multimodal physiotherapist program with virtual reality glasses.

Read the detailed description

In addition a physiotherapy program, virtual reality have a lot of importance advantages for train while motivated the kids.

A cross over study will be applied. In the control time, patient will received a initial evaluation and a final without making the physiotherapy program and without virtual reality glasses. The data will be collected by principal examiner.

In the intervention time the group will received 10 multimodal physiotherapy sessions, two or one per week, along six weeks. Also they are going to training walking with with virtual games.

Multimodal physiotherapist program describes the exercises to be performed, how long it will take, the number of repetitions and the way to do it with the physiotherapist in zoom session.

At the end of the multimodal physiotherapy program, variables will be evaluated by the principal examiner.

02

Conditions studied

  • Muscular Dystrophy, Duchenne and Becker Types

Keywords

  • Virtual Reality [L01.224.160.875], [L01.296.555]
  • Physical Therapy Modalities [E02.779], [E02.831.535]
  • Respiratory Therapy [E02.880]
  • Dystrophin [D12.776.210.500.250]
  • Becker Muscular Dystrophy [C10.668.491.175.500.300]
  • Resistance training [E02.831.535.483.875]
  • Muscular Stretching Therapy [E02.831.535.483.750]
03

In context

Muscular Dystrophies

548 studies on the registry are indexed under Muscular Dystrophies; 89 are open to participants now.

This study's enrollment of 12 is below the median of 24 across 344 interventional studies indexed under Muscular Dystrophies.

Browse Muscular Dystrophies studies →

Lead sponsor

University of Malaga is the lead sponsor of 118 studies on the registry; 34 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Years to 15 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Children between 4 and 15 years
  • Duchenne and Becker Diagnosis ICD-10 issued by specialist in neurology.
  • Children who can walk 10 m at last 120 seconds.
  • First punctuation of North Start Ambulatory assessment bigger than 20 points.

Exclusion criteria

Exclusion Criteria:

  • An other Dystrophies.
  • Older than 10 years.
  • Not Physiotherapy. Not walk.
  • Asociated heart disease Sprains, fractures. FC >120, Sat O2 \<89%.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
12 participants (actual)

Study arms

  • Experimental
    Multimodal physiotherapy program with RV

    The RV intervention group receives a tele multimodal physiotherapy program with tradicional exercises of physiotherapy like stretching, aerobic, training through videos and gamification with VR glasses.

    Other: multimodal physiotherapy program with RV

  • Active comparator
    Traditional physiotherapy program

    Traditional intervention group receives assistance of a program of physiotherapy traditional without virtual reality glasses.

    Other: traditional physiotherapy program

Interventions

  • Othermultimodal physiotherapy program with RV

    Physiotherapy Programm includes: respiratory physiotherapy, stretching, resistance training, aerobic training and adaptation and training with virtual reality glasses and relaxation.

  • Othertraditional physiotherapy program

    Multimodal physiotherapy Programm includes: traditional physiotherapy, stretching, massage.

06

What researchers measure

Primary outcomes

  1. Changes in six meter walking test (6-MWT) score

    Six-meter walking test is a a well-established outcome measure in a variety of diseases. It is accurate, reproducible, simple to administer, and well tolerated. The 6MWT is a robust assessment tool for use in clinical trials given its ability to quantitatively evaluate ambulation in a controlled environment.

    Time frame: Baseline, up to six weeks

Secondary outcomes

  1. EPInfant

    Scale of perceived child effort measurement EPInfant. It shows 11 numerical descriptors (0 to 10), 5 verbal descriptors located every 2 levels of intensity, and a set of illustrations that represent a child running at increasing intensities along a scale of bars of incremental height following a exponential type slope from left to right. The higher value represent a worse outcome.

    Time frame: through study completion, average 6 weeks

  2. NSAA o North Star Ambulatory Assessment

    Functional scale for children with DMD. It is expressed in points and evidences the acquisition of functions or the loss of them. Whilst DMD children may generally present with recognizable adaptations to activity due to the underlying progressive muscular weakness, they may modify their activity to achieve functional goals in slightly differing ways. Generally, activities are graded in the following manner: 2 - 'Normal' - no obvious modification of activity 1 - Modified method but achieves goal independent of physical assistance from another 0 - Unable to achieve independently. The better punctuation is 34 point, what mean the higher outcome.

    Time frame: Baseline, up to 6 weeks

  3. MFM o Motor Function Measure

    measure motor performance

    Time frame: Baseline, up to 6 weeks

  4. Kids Screen-52

    quality of life test

    Time frame: Baseline.

07

Study locations

1 site
  • Universidad de Málaga
    Málaga, 29071, Spain
08

References and documents

Publications

  • Baeza-Barragan MR, Labajos Manzanares MT, Ruiz Vergara C, Casuso-Holgado MJ, Martin-Valero R. The Use of Virtual Reality Technologies in the Treatment of Duchenne Muscular Dystrophy: Systematic Review. JMIR Mhealth Uhealth. 2020 Dec 8;8(12):e21576. doi: 10.2196/21576. PubMed 33289679 ↗
  • Baeza-Barragan MR, Labajos Manzanares MT, Amaya-Alvarez MC, Morales Vega F, Rodriguez Ruiz J, Martin-Valero R. Effectiveness of a 5-Week Virtual Reality Telerehabilitation Program for Children With Duchenne and Becker Muscular Dystrophy: Prospective Quasi-Experimental Study. JMIR Serious Games. 2023 Nov 15;11:e48022. doi: 10.2196/48022. PubMed 37990809 ↗

Individual participant data

Plan to share: No — an average of 2 years

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 13, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03879304
Lead sponsor
University of Malaga
Responsible party
Rosa Baeza Barragán (Principal Investigator, University of Malaga) — Principal investigator
First posted
Mar 18, 2019
Start date
Mar 15, 2021
Primary completion
Oct 30, 2022
Completion
Mar 11, 2023
Last update
May 13, 2024

Study contacts

Rocío Martín Valero, PhD
study director · Universidad de Málaga
Maria Teresa Labajos Manzanares, PhD
study director · Universidad de Málaga

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion